Efficacy and safety of nab-paclitaxel in patients with metastatic breast cancer: Final results of the non-interventional study NABUCCO.

Potthoff, K., Nusch, A., Söling, U., Hansen, R., Salat, Grebhardt, S., Marschner, N., 2016.

Ann Oncol (2016) 27 (suppl_6): 236P. doi:10.1093/annonc/mdw365.15

Studie: NABUCCO; Indikation: Mammakarzinom; Jahr: 2016; Veranstaltung: ESMO; Journal: Annals of Oncology

Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com